Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of the new Living Wage rate on community pharmacies.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
Pharmacy First was launched on 31 January 2024, and as the service embeds, we will monitor and evaluate the service and keep the conditions covered by Pharmacy First under review, but it is too early to consider expanding the clinical pathways.
In the Delivery plan for recovering access to primary care, we estimated that Pharmacy First, together with the expanded blood pressure check and contraception service, once fully scaled, could remove up to 10 million general practice (GP) appointments. We are monitoring the number of Pharmacy First consultations in community pharmacy but it is not possible to monitor the number of GP appointments Pharmacy First frees up. However, we know that Pharmacy First will enable GPs to see patients with more complex needs quicker.
Since 2019, GPs and their teams have already been referring patients to community pharmacies for minor illnesses and Pharmacy First builds on this. NHS England has engaged with GPs during the development and launch of Pharmacy First and Community Pharmacy England has launched a dedicated website for GPs supporting them with Pharmacy First referrals.
Pharmacies are not paid an establishment grant. Contractors who have signed up to deliver Pharmacy First received a £2,000 set-up fee, they receive £15 per consultation and £1,000 for each month they reach an agreed minimum number of consultations. Funding for community pharmacies, including the funding for Pharmacy First, is expected to pay for all their costs in providing the service. There are no delays to Pharmacy First payments. All payments are made in line with the usual schedule of payments.
The statutory National Minimum Wage and National Living Wage is based on advice of the Low Pay Commission, which takes into account the impact on business and the wider economy, as well as the living standards of workers.
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking to tackle delays to payments to community pharmacies operating Pharmacy First.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
Pharmacy First was launched on 31 January 2024, and as the service embeds, we will monitor and evaluate the service and keep the conditions covered by Pharmacy First under review, but it is too early to consider expanding the clinical pathways.
In the Delivery plan for recovering access to primary care, we estimated that Pharmacy First, together with the expanded blood pressure check and contraception service, once fully scaled, could remove up to 10 million general practice (GP) appointments. We are monitoring the number of Pharmacy First consultations in community pharmacy but it is not possible to monitor the number of GP appointments Pharmacy First frees up. However, we know that Pharmacy First will enable GPs to see patients with more complex needs quicker.
Since 2019, GPs and their teams have already been referring patients to community pharmacies for minor illnesses and Pharmacy First builds on this. NHS England has engaged with GPs during the development and launch of Pharmacy First and Community Pharmacy England has launched a dedicated website for GPs supporting them with Pharmacy First referrals.
Pharmacies are not paid an establishment grant. Contractors who have signed up to deliver Pharmacy First received a £2,000 set-up fee, they receive £15 per consultation and £1,000 for each month they reach an agreed minimum number of consultations. Funding for community pharmacies, including the funding for Pharmacy First, is expected to pay for all their costs in providing the service. There are no delays to Pharmacy First payments. All payments are made in line with the usual schedule of payments.
The statutory National Minimum Wage and National Living Wage is based on advice of the Low Pay Commission, which takes into account the impact on business and the wider economy, as well as the living standards of workers.
Asked by: Tanmanjeet Singh Dhesi (Labour - Slough)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent assessment her Department has made of the impact of the Strikes (Minimum Service Levels) Act 2023 on the ability of healthcare professionals to participate in industrial action.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Strikes (Minimum Service Levels) Act 2023 allows for regulations to be laid in Parliament in the health sector. The Strikes (Minimum Service Levels: NHS Ambulance Services and the NHS Patient Transport Service) Regulations 2023 came into force on 8 December 2023.
As we set out in in our consultation response on minimum service levels in the ambulance sector, in our engagement with representatives from ambulance trusts, they indicated that establishing a minimum service level at the level specified in the regulations would require approximately 80% of an ambulance service’s resources on a typical shift. Therefore, if an employer chose to issue work notices during a strike, it is likely that a high proportion of all levels of paramedics, emergency care assistants, and other staff in the ambulance teams rostered to work on a strike would be named, and this would have a significant impact on the ability of employees to participate in strike action. The Department has consulted on whether to implement similar regulations for hospital services, and will set out its response in due course.
Asked by: Alison McGovern (Labour - Wirral South)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to improve the treatment of Cholangiocarcinoma cancers; and whether a proportion of the additional funding allocated to her Department in the Spring Budget 2024 will be used to treat Cholangiocarcinoma cancers.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
Cancer is being diagnosed at an earlier stage, more often, with survival rates improving across almost all types of cancer, and the National Health Service has been seeing and treating record numbers of cancer patients over the last two years. Improving early diagnosis of cancer, including cholangiocarcinoma cancers, is a priority for the NHS. The NHS has an ambition to diagnose 75% of cancers at stage 1 or 2 by 2028, which will help tens of thousands of people live for longer.
Although funding for treatment isn’t allocated for specific cancers, the Government has provided significant additional funding to the NHS and adult social care in England. Measures introduced at the Spring Budget will protect levels of funding for the NHS in England in real terms in 2024/25, by providing an extra £2.5 billion for 2024/25, meaning a total budget of £164.9 billion.
While this additional spending is needed, the Government recognises that more money cannot always be the answer to improving outcomes for patients. Alongside the £2.5 billion of extra funding for day-to-day activities, the Government will invest £3.4 billion to reform the way the NHS works. This funding will significantly reduce the 13 million hours of time doctors spend on poor IT, freeing up significant capacity, and revolutionising treatment for a range of illnesses such as cancer and strokes. This will double the investment in technological and digital transformation in the NHS in England, and turn the NHS into one of the most digitally enabled, productive healthcare systems in the world.
On 14 August 2023, the Government published the Major Conditions Strategy’s Case for Change and Our Strategic Framework, which sets out our approach to making the choices over the next five years that will deliver the most value when facing the health challenges of today and of the decades ahead, including for cancer. It will look at the treatment and prevention of cancer, covering the patient pathway. The strategy will look at a wide range of interventions and enablers, to improve outcomes and experience for cancer patients.
Asked by: Dawn Butler (Labour - Brent Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent assessment she has made of trends in the level of uptake for breast cancer screenings amongst ethnic minority women.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The national breast screening programme does not currently have the capability to routinely cross reference patient’s ethnicity data with uptake data. NHS England has started work to improve its data collection capabilities as part of the development of the new screening IT system, through the Digital Transformation of Screening programme. This will support the collection of population-level data on protected characteristics such as ethnicity, to support services in improving uptake.
More widely, NHS England has developed a national plan to improve uptake, including interventions to address inequalities and screening barriers. This includes ensuring appointments are as convenient as possible, and efforts are focused on areas and groups with low uptake.
Asked by: Tulip Siddiq (Labour - Hampstead and Kilburn)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the potential implications for her policies of Pancreatic Cancer UK's Optimal Care Pathway recommendations.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
NHS England is delivering a range of interventions that are expected to increase early diagnosis, and improve outcomes for those with pancreatic cancer. This includes providing a route into pancreatic cancer surveillance for those at inherited high-risk, to identify lesions before they develop into cancer and diagnose cancers sooner, creating new pathways to support faster referral routes for people with non-specific symptoms that could be linked to a range of cancer types, and increasing general practice direct access to diagnostic tests. NHS England has also formed an expert group to consider a pathway for hepato-pancreato-biliary cancers, including pancreatic cancer.
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether she plans to develop vaping cessation programmes.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
Vaping can be an effective tool for adult smokers to quit smoking. However, the health advice is clear, if you don’t smoke, don’t vape, and children should never vape. We are concerned about the worrying rise in vaping among children, with youth vaping tripling in the last three years, and one in five children having now used a vape.
Whilst anyone smoking should focus on giving up cigarettes before giving up vaping, giving up vaping is an important step in overcoming nicotine dependence. We are working with the NHS Better Health website to provide advice for people who want to quit vaping. The National Centre for Smoking Cessation and Training has produced guidance for local Stop Smoking Service staff on how best to support vapers to quit. We are also exploring further ways to support people to quit vaping, as part of the national Swap to Stop programme.
Asked by: Elliot Colburn (Conservative - Carshalton and Wallington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking to help improve the knowledge of GPs on the symptoms of young onset dementia.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
We want all general practitioners to have received appropriate training, in order to provide high quality care to people with dementia, regardless of the person’s age or individual needs.
The standard of training for health care professionals is the responsibility of the health care independent statutory regulatory bodies who set the outcome standards expected at undergraduate level and approve courses and Higher Education Institutions to write and teach the curricula content that enables their students to meet the regulators outcome standards.
Whilst not all curricula may necessarily highlight a specific condition, they all nevertheless emphasize the skills and approaches a Health Care Practitioner must develop in order to ensure accurate and timely diagnoses and treatment plans for their patients, including for dementia.
The NHS Long Term Workforce Plan, published on 30 June 2023, sets out NHS England’s commitment to improving training for workers caring for people with dementia.
The Long Term plan also sets out the plan for there to be more healthcare staff working in and with GP practices, which will mean people will be able to get an appointment with the right professional depending on their needs. This means that those with dementia will be able to access the most appropriate support more quickly.
The plan will include more GPs, nurses and 20,000 additional pharmacists, physiotherapists, paramedics, physician associates and social prescribing link. These bigger teams of staff will work with other local services to make sure people, including those with dementia, get better access to a wider range of support for their needs.
We are seeing more people from younger cohorts with multimorbidity. Multimorbidity challenges the specialised approach to medicine, which has improved our ability to successfully treat single diseases. The Long Term Plan also addresses the increased need for medical and other clinical professionals with generalist and core skills to manage and support patients with seemingly unrelated diseases.
There are also a variety of resources available on the NHS England E-learning for Health platform, including a programme on dementia care, designed to enhance the training and education of the health and social care workforce.
Asked by: Stephen Timms (Labour - East Ham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if NHS England will (a) fund and (b) publish a data dashboard to help integrated care boards commission children and young people’s palliative and end of life care.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
NHS England has developed an all-age palliative and end of life care dashboard, which brings together all relevant local data in one place in an easily accessible format. The dashboard is accessible to integrated care boards (ICBs) and their commissioners and helps them understand the palliative and end of life care needs of their local population, including children and young people. This supports commissioners in their statutory duty for palliative and end of life care, enabling ICBs to put plans in place to address and track the improvement of health inequalities, and ensure that funding is distributed fairly based on prevalence.
Funding has been confirmed to ensure continued maintenance of the dashboard for 2024/25, with discussions ongoing regarding further development and use. There is, however, existing publicly available data, such as the Office for Health Improvement and Disparities ‘Fingertips’ data on palliative and end of life care.
Asked by: Peter Dowd (Labour - Bootle)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure that health and social care professionals are trained in Parkinson’s-related dementia care.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
The standard of training for health care professionals is the responsibility of the health care independent statutory regulatory bodies. They set the outcome standards expected at undergraduate level and approve courses and Higher Education Institutions to write and teach the curricula content that enables their students to meet the regulators outcome standards.
Whilst not all curricula may necessarily highlight a specific condition, they all nevertheless emphasize the skills and approaches a health care practitioner must develop in order to ensure accurate and timely diagnoses and treatment plans for their patients, including for dementia.
Individual employers across health and social care are responsible for ensuring their staff are trained and competent to carry out their role, and for investing in the future of their staff by providing continuing professional development (CPD) funding. The required training needs are set out in the Dementia Training Standards Framework, which is available at the following link:
https://www.skillsforhealth.org.uk/info-hub/dementia-2015-updated-2018/
The framework was commissioned and funded by the Department, and developed in collaboration with the sector. It sets out the essential knowledge, skills, and expected learning outcomes applicable across the health and care spectrum.
It is applicable to health and social care staff who work with people living with dementia, staff providing direct care and support, and those who provide leadership in transforming care, including social care managers and leaders.
To supplement local National Health Service employer investment for CPD, the NHS Long Term Workforce Plan, published on 30 June 2023, sets out NHS England’s commitment to continue national CPD funding for nurses, midwives, and allied health professionals. There are a variety of resources available on the NHS England e-learning for health platform, designed to enhance the training and education of the health and social care workforce. This includes a programme on dementia care, and modules in Parkinson’s disease in geriatric medicine.